Kyowa Hakko Kirin Co., Limited

Tomoyuki Nakazato

Takeshi Takahashi

Yutaka Kanda

Yoshinori Yamashita

Shinji Nara

Masayo Suzuki

Takamasa Sugita

Keiko Kawashima

Hiromi Ando

Hisashi Tagaya

Hiroaki Nakamura

The present invention provides a type I insulin-like growth factor receptor (IGF-1R) inhibitor comprising, as an active ingredient, an indazole derivative represented by Formula (I): {wherein Rrepresents &#x2014;NRR[wherein Rrepresents a hydrogen atom or the like, Rrepresents substituted or unsubstituted lower alkyl, &#x2014;C(&#x2550;O)R(wherein Rrepresents substituted or unsubstituted lower alkyl, substituted or unsubstituted aryl or the like), or the like], or the like, and Rand Rmay be the same or different and each represents a hydrogen atom, hydroxy, substituted or unsubstituted lower alkoxy, or the like} or a pharmaceutically acceptable salt thereof, and the like.

IGF-1R inhibitor

Growing community of inventors

Sunto-gun, Japan

Tomoyuki Nakazato